Patricia Rohane

Patricia Rohane has a diverse work experience in the pharmaceutical industry. Patricia is currently working as the Vice President of Therapeutic Strategy at IQVIA since May 2019. Prior to this, they served as the Vice President of Clinical Development at CymaBay Therapeutics from September 2018.

Patricia has also worked at renowned companies such as Sanofi, where they held the positions of Associate Vice President and Senior Clinical Director from August 2013 to present. At Celgene Corporation, they served as the Vice President of Clinical Research and Development, Immunology and Inflammation, where they led the Inflammation Therapeutic Area and successfully developed an oral PDE4 inhibitor.

Patricia also founded their own company, Applied Clinical Tactics, LLC, where they served as the President and Managing Member. Patricia has also held the position of Vice President of Clinical Research, Allergy Therapeutic Area at Schering-Plough Research Institute. At Novartis, they worked as a Senior Clinical Director, leading the international clinical project team for Xolair and achieving its initial approval.

Patricia Rohane began their education at The University of New Mexico, where they obtained a Bachelor of Science with Distinction degree in Biology, Immunology, Biochemistry, and Chemistry from 1975 to 1979. Patricia then pursued a Medical Doctor (MD) degree at The University of New Mexico School of Medicine from 1980 to 1984. Following this, they completed a residency program in Internal Medicine at Baylor College of Medicine from 1984 to 1987. Patricia further specialized in the field of Allergy and Immunology at Baylor College of Medicine from 1988 to 1991. Additionally, they attended Stanford University School of Medicine in 1991, focusing on Immunology. No specific degree was mentioned for their time at Stanford University School of Medicine.